Intrauterine growth retardation and fetal cardiac function
- PMID: 10705209
- DOI: 10.1159/000020969
Intrauterine growth retardation and fetal cardiac function
Abstract
Intrauterine growth retardation is a pathology which is found in 3-10% of all pregnancies and it is associated with around 20-25% of all fetal intrauterine deaths and with long-term neurologic sequelae. It presents an increased risk of distress during labor and delivery and a greater risk of perinatal mortality. The causes of IUGR and the cardiac and venous Doppler in normal fetuses are analyzed, and the hemodynamic cardiac modifications in IUGR fetus are discussed. The fetal cardiac function in intrauterine growth retardation shows a redistribution of the fetal cardiac output, which tends to favor the left ventricle as the mechanism to compensate for the uteroplacental insufficiency. The Doppler velocity indices are modified as the fetal condition progressively deteriorates and they represent an important tool for the management of the complicated pregnancy.
Copyright 2000 S. Karger AG, Basel.
Similar articles
-
Echocardiography in intrauterine growth restriction.Clin Obstet Gynecol. 1997 Dec;40(4):796-803. doi: 10.1097/00003081-199712000-00014. Clin Obstet Gynecol. 1997. PMID: 9429794 Review. No abstract available.
-
Alterations in time intervals of ductus venosus and atrioventricular flow velocity waveforms in growth-restricted fetuses.Ultrasound Obstet Gynecol. 2015 Aug;46(2):221-6. doi: 10.1002/uog.14717. Ultrasound Obstet Gynecol. 2015. PMID: 25366537
-
Clinical application of fetal left modified myocardial performance index in the evaluation of fetal growth restriction.J Perinat Med. 2015 Nov;43(6):749-54. doi: 10.1515/jpm-2014-0018. J Perinat Med. 2015. PMID: 24706424 Clinical Trial.
-
[Doppler flow characteristics in ductus venosus between 22-42 weeks in intrauterine growth restriction and normal pregnancies].Ginekol Pol. 2005 May;76(5):358-64. Ginekol Pol. 2005. PMID: 16145854 Polish.
-
Doppler studies of deteriorating growth-retarded fetuses.Curr Opin Obstet Gynecol. 1993 Apr;5(2):195-203. Curr Opin Obstet Gynecol. 1993. PMID: 8490089 Review.
Cited by
-
Interventions affecting the nitric oxide pathway versus placebo or no therapy for fetal growth restriction in pregnancy.Cochrane Database Syst Rev. 2023 Jul 10;7(7):CD014498. doi: 10.1002/14651858.CD014498. Cochrane Database Syst Rev. 2023. PMID: 37428872 Free PMC article. Review.
-
Do small for gestational age fetuses have placental pathologies?Arch Gynecol Obstet. 2024 Apr;309(4):1305-1313. doi: 10.1007/s00404-023-06989-8. Epub 2023 Mar 18. Arch Gynecol Obstet. 2024. PMID: 36933038
-
Comparative evaluation of echocardiography indices during the transition to extrauterine life between small and appropriate for gestational age infants.Front Pediatr. 2023 Jan 16;10:1045242. doi: 10.3389/fped.2022.1045242. eCollection 2022. Front Pediatr. 2023. PMID: 36727000 Free PMC article.
-
Modified myocardial performance index for evaluation of fetal heart function and perinatal outcomes in intrahepatic pregnancy cholestasis.Int J Cardiovasc Imaging. 2023 May;39(5):907-914. doi: 10.1007/s10554-022-02789-4. Epub 2023 Jan 6. Int J Cardiovasc Imaging. 2023. PMID: 36607472
-
Maternal Low Volume Circulation Relates to Normotensive and Preeclamptic Fetal Growth Restriction.Front Med (Lausanne). 2022 Jun 9;9:902634. doi: 10.3389/fmed.2022.902634. eCollection 2022. Front Med (Lausanne). 2022. PMID: 35755049 Free PMC article. Review.
MeSH terms
LinkOut - more resources
Full Text Sources
